Pharma Aids Limited (DSE:PHARMAID)
499.20
+0.40 (0.08%)
At close: Jan 22, 2026
Pharma Aids Market Cap
Pharma Aids has a market cap or net worth of 1.56 billion as of January 23, 2026. Its market cap has decreased by -12.68% in one year.
Market Cap
1.56B
Enterprise Value
1.54B
Revenue
453.49M
Ranking
n/a
PE Ratio
23.11
Stock Price
499.20
Market Cap Chart
Since August 5, 2004, Pharma Aids's market cap has increased from 8.88M to 1.56B, an increase of 17,441.44%. That is a compound annual growth rate of 27.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.56B | 3.12% |
| Dec 30, 2025 | 1.51B | -15.56% |
| Dec 30, 2024 | 1.79B | -27.49% |
| Dec 28, 2023 | 2.47B | - |
| Dec 29, 2022 | 2.47B | 31.70% |
| Dec 30, 2021 | 1.87B | 26.48% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 6.66B |
| Orion Pharma | 6.51B |
| Navana Pharmaceuticals | 5.80B |
| Techno Drugs | 4.17B |
| Ambee Pharmaceuticals | 1.70B |
| Silco Pharmaceuticals | 1.47B |
| Silva Pharmaceuticals | 1.45B |
| Libra Infusions | 1.42B |